Search Results

Business

Microbiotica Announces Transition of Leadership

Microbiotica announces a change of leadership as Mike Romanos hands over the Microbiotica CEO role to current COO, Tim Sharpington.

November 29, 2022

·

4 min read

Business

Microbiotica Announces Clinical Trial Collaboration with MSD to Evaluate MB097 in Combination with KEYTRUDA® (pembrolizumab) in a Phase 1b Clinical Trial in Melanoma

Microbiotica today announces it has entered into a clinical trial collaboration with MSD (Merck & Co., Inc., Rahway, NJ, USA).

April 12, 2023

·

3 min read

Microbiotica Raises £50m ($67m) to Advance Pipeline of Microbiome-based Therapeutics

Microbiotica today announced the completion of a £50 million ($67 million) Series B financing round – the largest microbiome-related financing in Europe to date.

March 7, 2022

·

9 min read

Drug Development

Microbiotica’s Live Bacterial Therapeutic, MB097, in development to begin clinical trials in 2022 in immuno-oncology

Microbiotica today announces that MB097 is now in pre-clinical development for treatment of patients not responding to anti-PD1 therapy. Clinical trials are due to begin in 2022.

June 23, 2021

·

5 min read

Business

Microbiotica relocates to Chesterford Research Park, Cambridge

Chesterford Research Park and Microbiotica, a leading player in microbiome-based therapeutics and biomarkers, announce that Microbiotica is relocating to the Park in a two-phase move that will be completed in June 2020.

November 19, 2019

·

6 min read

Business

Microbiotica, Cancer Research UK and Cambridge University Hospitals Collaborate in Landmark Cancer Microbiome Study

Microbiotica, a leading player in microbiome-based therapeutics and biomarkers, Cancer Research UK and Cambridge University Hospitals NHS Foundation Trust, announce a collaboration to identify and develop microbiome co-therapeutics and biomarkers for cancer patients receiving immune checkpoint inhibitor therapy.

June 8, 2020

·

8 min read

Business

Microbiotica Appoints Thomas Lynch as Independent Non-Executive Chairman

Microbiotica, a leading player in microbiome-based therapeutics and biomarkers, announces the appointment of Thomas Lynch as the new non-Executive Chairman of its Board, from 1 September 2019.

September 25, 2019

·

5 min read

Microbiotica Presenting at Key Industry Events during Summer 2019

Microbiotica, a leading player in microbiome-based therapeutics, is pleased to confirm upcoming conference attendance and during summer 2019.

June 20, 2019

·

4 min read

Microbiotica Presenting at Key Microbiome Events in Q1 2019

Microbiotica, a leading player in microbiome-based therapeutics, is pleased to confirm upcoming conference activity for the first quarter of 2019.

January 28, 2019

·

3 min read

Microbiotica to Present at Top Microbiome Conferences

Microbiotica announces that it will present at leading microbiome conferences throughout May and June.

May 22, 2018

·

2 min read